Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardiovascular Risk Markers in Patients With Rheumatoid Arthritis: Effect of Rituximab Therapy

NCT00844714 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT00844714
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00844714 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardiovascular Risk Markers in Patients With Rheumatoid Arthritis: Effect of Rituximab Therapy
Lead sponsor
University of California, San Francisco
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2009
Completion date
December 31, 2014
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endothelial function, inflammation, rheumatoid arthritis